| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |